EcoR1 Capital, LLC
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it. Buying this fund's new positions the day each filing went public, over 30 quarters, returned +1.1% per quarter versus +1.9% from simply owning every 13F stock — it beat that baseline in only 40.0% of quarters (excess t = -2.88). Copying it would have systematically underperformed the simplest possible strategy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 29 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| ZYME | $575M | | HOLD |
| ANAB | $437M | | HOLD |
| JAZZ | $323M | | HOLD |
| CNTA | $238M | | ADD |
| CRNX | $156M | | HOLD |
| AKTS | $86M | | NEW |
| ORIC | $85M | | HOLD |
| CGON | $75M | | ADD |
| CRSP | $66M | | HOLD |
| ETON | $54M | | ADD |
| LKFT | $50M | | HOLD |
| XNCR | $26M | | TRIM |
| NGNE | $26M | | HOLD |
| BBOT | $25M | | HOLD |
| MBX | $23M | | TRIM |
| RLAY | $19M | | NEW |
| ZBIO | $15M | | HOLD |
| ERAS | $15M | | NEW |
| EIKN | $8M | | NEW |
| REPL | $8M | | NEW |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.